Genmab A (GMAB) Cash from Discontinued Operations (2024 - 2025)
Genmab A (GMAB) posted Cash from Discontinued Operations of 287000000.0 for Q1 2025, down 94.33% on a QoQ basis from 5059000000.0 in Q3 2024, and up 31.05% year-over-year from 219000000.0 in Q1 2024.
Genmab A (GMAB) Cash from Discontinued Operations (2024 - 2025) Analysis & Trends
Genmab A's Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 287000000.0 for Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | - |
| 2 | Nanobiotix | 1,905.61 Bn | 1,905.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,011.81 Bn | 1,011.81 Bn | - | - |
| 4 | BeOne Medicines | 467.29 Bn | 462.50 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.89 Bn | 115.65 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.64 Bn | 34.63 Bn | 959.66 Mn | - |
| 10 | Genmab A | 1.88 Bn | 355.59 Mn | 831.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 287.00 Mn |
| Mar 31, 2025 | 287.00 Mn |
| Sep 30, 2024 | 5.06 Bn |
| Sep 30, 2024 | 5.06 Bn |
| Mar 31, 2024 | 219.00 Mn |
| Mar 31, 2024 | 219.00 Mn |